Oncotarget

Research Papers:

Identification of LEFTY as a molecular marker for ovarian clear cell carcinoma

Masashi Akiya, Masaaki Yamazaki, Toshihide Matsumoto, Yusuke Kawashima, Yasuko Oguri, Sabine Kajita, Daiki Kijima, Risako Chiba, Ako Yokoi, Hiroyuki Takahashi, Yoshio Kodera and Makoto Saegusa _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:63646-63664. https://doi.org/10.18632/oncotarget.18882

Metrics: PDF 1738 views  |   HTML 3212 views  |   ?  


Abstract

Masashi Akiya1, Masaaki Yamazaki1, Toshihide Matsumoto1, Yusuke Kawashima2, Yasuko Oguri1, Sabine Kajita1, Daiki Kijima1, Risako Chiba1, Ako Yokoi1, Hiroyuki Takahashi1, Yoshio Kodera2 and Makoto Saegusa1

1Department of Pathology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan

2Center for Disease Proteomics, School of Science, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan

Correspondence to:

Makoto Saegusa, email: [email protected]

Keywords: LEFTY, ovarian clear cell carcinoma, cell proliferation, apoptosis, TGF-beta

Received: November 22, 2016     Accepted: June 11, 2017     Published: June 29, 2017

ABSTRACT

To identify proteins involved in ovarian clear cell carcinoma (OCCCa), shotgun proteomics analysis was applied using formalin-fixed and paraffin-embedded samples of ovarian carcinoma. Analysis of 1521 proteins revealed that 52 were differentially expressed between four OCCCa and 12 non-OCCCa samples. Of the highly expressed proteins in OCCCa, we focused on left-right determination factor (LEFTY), a novel member of the transforming growth factor-β superfamily. In 143 cases of ovarian epithelial carcinoma including 99 OCCCas and 44 non-OCCCas, LEFTY expression at both mRNA and protein levels was significantly higher in OCCCas compared with non-OCCCas, with the mRNA expression of LEFTY1 being predominant compared to that of LEFTY2. OCCCa cells stably overexpressing LEFTY1 showed reduced cell proliferation, along with decreased pSmad2 expression, and also either displayed an activated p53/p21waf1 pathway or increased p27kip1 expression, directly or indirectly. Moreover, the treatment of stable cell lines with cisplatin led to increased apoptotic cells, together with the inhibition of protein expression of a pSmad2-mediated X-linked inhibitor of apoptosis and a decreased bcl2/bax ratio. Blocking LEFTY1 expression with a specific short hairpin RNA inhibited cisplatin-induced apoptosis, probably through the increased expression of both XIAP and bcl2, but not bax. In clinical samples, a significantly higher number of apoptotic cells and lower Ki-67 labeling indices were observed in OCCCas with a high LEFTY score relative to those with a low score. These findings suggest that LEFTY may be an excellent OCCCa-specific molecular marker, which has anti-tumor effects in altering cell proliferation and cellular susceptibility to apoptosis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18882